Atlas Trials

House Dust Mite Allergy

24 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch House Dust Mite Allergy

RecordFirmDate
Efficacy and Safety Assessment of Beltavac® With Polymerized Extract of HDM (NCT05395689)Probelte Pharma S.L.U.2022-01-17
Skin Responses and T Cell Immunology After House Dust Mite Exposure in Sensitized Atopic Dermatitis Patients (NCT05019209)Fraunhofer-Institute of Toxicology and Experimental Medicine2021-09-10
Epigenetic Regulation of Exercise Induced Asthma (NCT05174689)Johann Wolfgang Goethe University Hospital2021-08-01
Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis (NCT04874714)Inmunotek S.L.2021-04-30
Safety and Clinical Tolerability of hdmASIT+TM Peptides Administered in HDM-induced Allergic Patients (NCT03094845)ASIT Biotech S.A.2016-09-28
Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR (NCT02443805)Stallergenes Greer2015-09-29
SUBLIVAC FIX Mite Mixture Dose Tolerability Study (NCT02345278)HAL Allergy2015-05-01
AZELASTINE/FLUTICASONE (AZE/FLU) Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR) (NCT02238353)Universitaire Ziekenhuizen KU Leuven2014-10-01
Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma (NCT01930461)Stallergenes Greer2013-09-01
ToleroMune House Dust Mite Follow on Study (NCT01923792)Circassia Limited2013-09-01
Role of the Central Nervous System in Allergic Rhinitis (NCT01777464)Universitaire Ziekenhuizen KU Leuven2012-11-01
Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts (NCT01608243)Stallergenes Greer2012-05-01
A One Year Trial Evaluating the Safety and Efficacy of the ALK House Dust Mite Allergy Tablet (NCT01454544)ALK-Abelló A/S2011-10-01
Safety of Bronchial Allergen Challenge and Predictors for Positive Reaction. (NCT01134757)Johann Wolfgang Goethe University Hospital2011-01-01
A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis (NCT00574223)Cytos Biotechnology AG2007-11-01
A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis (NCT00574704)Cytos Biotechnology AG2006-09-01
Fish Oil and Asthma in House Dust Mite Allergy (NCT00380926)Johann Wolfgang Goethe University Hospital2004-04-01
Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis (NCT00263549)Allergopharma GmbH & Co. KG2002-09-01

Track House Dust Mite Allergy automatically

Every clearance here is in the API, with alerts when new ones post.